The modulation of endothelial cell gene expression by green tea polyphenol-EGCG

Molecular Nutrition and Food Research

Volumn 52, Issue 10, 2008, Pages 1182-1192

  Liu, Liping ^a   Lai, Chao Qiang ^a   Nie, Lin ^a   Ordovas, Jose ^a   Band, Michael ^a   Moser, Leta ^a   Meydani, Mohsen ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

EGCG; Endothelial cell; MAPP analysis; Microarray; Proliferation

Indexed keywords

CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; TEA;

CATECHIN; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FLAVONOIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; PHENOLS; TEA; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 55449105561     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700499     Document Type: Article

References (58)

1. Kono, S., Ikeda, M., Tokudome, S., Kuratsune, M., A case-control study of gastric cancer and diet in northern Kyushu, Japan, Jpn. J. Cancer Res. 1988, 79, 1067-1074.
2. Gao, Y. T., McLaughlin, J. K., Blot, W. J., Ji, B. T., et al., Reduced risk of esophageal cancer associated with green tea consumption, J. Natl. Cancer Inst. 1994, 86, 855-858.
3. Setiawan, V. W., Zhang, Z. F., Yu, G. P., Lu, Q. Y., et al., Protective effect of green tea on the risks of chronic gastritis and stomach cancer, Int. J. Cancer 2001, 92, 600-604.
4. Bushman, J. L., Green tea and cancer in humans: A review of the literature, Nutr. Cancer 1998, 31, 151-159.
5. Rogers, A. E., Hafer, L. J., Iskander, Y. S., Yang, S., Black tea and mammary gland carcinogenesis by 7,12-dimethylben[a]-anthracene in rats fed control or high fat diets, Carcinogenesis 1998, 19, 1269-1273.
6. Lyn-Cook, B. D., Rogers, T., Yan, Y., Blann, E. B., et al., Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro, Nutr. Cancer 1999, 35, 80-86.
7. Park, A. M., Dong, Z., Signal transduction pathways: Targets for green and black tea polyphenols, J. Biochem. Mol. Biol. 2003, 36, 66-77.
8. Jung, Y. D., Ellis, L. M., Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea, Int. J. Exp. Pathol. 2001, 82, 309-316.
9. Cao, Y., Cao, R., Angiogenesis inhibited by drinking tea, Nature 1999, 398, 381.
10. Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med. 1995, 1, 27-31.
11. Carmeliet, P., Jain, R. K., Angiogenesis in cancer and other diseases, Nature 2000, 407, 249-257.
12. Tang, F. Y., Meydani, M., Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production, Nutr. Cancer 2001, 41, 119-125.
13. Tang, F. Y., Nguyen, N., Meydani, M., Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule, Int. J. Cancer 2003, 106, 871-878.
14. Jankun, J., Selman, S. H., Swiercz, R., Skrzypczak-Jankun, E., Why drinking green tea could prevent cancer, Nature 1997, 387, 561.
15. Jankun, J., Keck, R. W., Skrzypczak-Jankun, E., Swiercz, R., Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice, Cancer Res. 1997, 57, 559-563.
16. Garbisa, S., Sartor, L., Biggin, S., Salvato, B. et al., Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate, Cancer 2001, 91, 822-832.
17. Abe, M., Sato, Y., cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells, Angiogenesis 2001, 4, 289-298.
18. Grant, D. S., Lelkes, P. I., Fukuda, K., Kleinman, H. K., Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro, In Vitro Cell Dev. Biol. 1991, 27A, 327-336.
19. Baldi, P., Long, A. D., A Bayesian framework for the analysis of microarray expression data: Regularized t-test and statistical inferences of gene changes, Bioinformatics 2001, 17, 509-519.
20. Choe, S. E., Boutros, M., Michelson, A. M., Church, G. M., Halfon, M. S., Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset, Genome Biol. 2005, 6, R16.
21. Storey, J. D., Tibshirani, R., Statistical significance for genomewide studies, Proc. Natl. Acad. Sci. USA 2003, 100, 9440-9445.
22. Dahlquist, K. D., Salomonis, N., Vranizan, K., Lawlor, S. C., Conklin, B. R., GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways, Nat. Genet. 2002, 31, 19-20.
23. Doniger, S. W., Salomonis, N., Dahlquist, K. D., Vranizan, K. et al., MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data, Genome Biol. 2003, 4, R7.
24. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., Hattori, M., The KEGG resource for deciphering the genome, Nucleic Acids Res. 2004, 32, D277-D280.
25. Osada, R., Horiuchi, A., Kikuchi, N., Ohira, S., et al., Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: Increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas, Hum. Pathol. 2006, 37, 1414-1425.
26. Cai, J., Jiang, W. G., Ahmed, A., Boulton, M., Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS, Microvasc. Res. 2006, 71, 20-31.
27. Rodriguez, S. K., Guo, W., Liu, L., Band, M. A., et al., Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex, Int. J. Cancer 2006, 118, 1635-1644.
28. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., et al., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis, Cell 1993, 72, 835-846.
29. Gerritsen, M. E., Tomlinson, J. E., Zlot, C., Ziman, M., Hwang, S., Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells, Br. J. Pharmacol. 2003, 140, 595-610.
30. Kallmann, B. A., Wagner, S., Hummel, V., Buttmann, M., et al., Characteristic gene expression profile of primary human cerebral endothelial cells, FASEP J. 2002, 16, 589-591.
31. Tachibana, I., Imoto, M., Adjei, P. N., Gores, G. J., et al., Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells, J. Clin. Invest. 1997, 99, 2365-2374.
32. Ribeiro, A., Bronk, S. F., Roberts, P. J., Urrutia, R., Gores, G. J., The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress, Hepatology 1999, 30, 1490-1497.
33. Wakasugi, K., Slike, B. M., Hood, J., Otani, A., et al., A human aminoacyl-tRNA synthetase as a regulator of angiogenesis, Proc. Natl. Acad. Sci. USA 2002, 99, 173-177.
34. Otani, A., Slike, B. M., Dorrell, M. I., Hood, J., et al., A fragment of human TrpRS as a potent antagonist of ocular angiogenesis, Proc. Natl. Acad. Sci. USA 2002, 99, 178-183.
35. Tzima, E., Reader, J. S., Irani-Tehrani, M., Ewalt, K. L., et al., VE-cadherin links tRNA synthetase cytokine to antiangiogenic function, J. Biol. Chem. 2005, 280, 2405-2408.
36. Liang, Y. C., Lin-shiau, S. Y., Chen, C. F., Lin, J. K., Suppression of extracellular signals and cell proliferation through EGF receptor binding by ( -)-epigallocatechin gallate in human A431 epidermoid carcinoma cells, J. Cell. Biochem. 1997, 67, 55-65.
37. Chen, A., Zhang, L., Xu, J., Tang, J., The antioxidant ( -)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression, Biochem. J. 2002, 368, 695-704.
38. Vittal, R., Selvanayagam, Z. E., Sun, Y., Hong, J., et al., Gene expression changes induced by green tea polyphenol ( -)-epigallocatechin-3- gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray, Mol. Cancer Ther. 2004, 3, 1091-1099.
39. Ahn, W. S., Huh, S. W., Bae, S. M., Lee, I. P., et al., A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression, DNA Cell Biol. 2003, 22, 217-224.
40. Wang, S. I., Mukhtar, H., Gene expression profile in human prostate LNCaP cancer cells by ( -)-epigallocatechin-3-gallate, Cancer Lett. 2002, 182, 43-51.
41. Eisenberg, L. M., Eisenberg, C. A., Wnt signal transduction and the formation of the myocardium, Dev Biol. 2006, 293, 305-315.
42. Goodwin, A. M., Sullivan, K. M., D'Amore, P. A., Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling, Dev. Dyn. 2006, 235, 3110-3120.
43. Masckauchan, T. N., Agalliu, D., Vorontchikhina, M., Ahn, A. et al., Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2, Mol. Biol. Cell 2006, 17, 5163-5172.
44. Masckauchan, T. N., Kitajewski, J., Wnt/Frizzled signaling in the vasculature: New angiogenic factors in sight, Physiology (Bethesda) 2006, 21, 181-188.
45. Huang, H. C., Klein, P. S., The Frizzled family: Receptors for multiple signal transduction pathways, Genome Biol. 2004, 5, 234.
46. Logan, C. Y., Nusse, R., The Wnt signaling pathway in development and disease, Annu. Rev. Cell Dev. Biol. 2004, 20, 781-810.
47. He, X., Semenov, M., Tamai, K., Zeng, X., LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: Arrows point the way, Development 2004, 131, 1663-1677.
48. Hui, C. M., Cheung, P. Y., Ling, M. T., Tsao, S. W., et al., Id-1 promotes proliferation of p53-deficient esophageal cancer cells, Int. J. Cancer 2006, 119, 508-514.
49. Bae, S., Bessho, Y., Hojo, M., Kageyama, R., The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation, Development 2000, 127, 2933-2943.
50. Ishiko, E., Matsumura, I., Ezoe, S., Gale, K., et al., Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1, J. Biol. Chem. 2005, 280, 4929-4939.
51. Kondo, T., Ohta, T., Igura, K., Hara, Y., Kaji, K., Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding, Cancer Lett. 2002, 180, 139-144.
52. Tachibana, H., Koga, K., Fujimura, Y., Yamada, K., A receptor for green tea polyphenol EGCG, Nat. Struct. Mol. Biol. 2004, 11, 380-381.
53. Haslam, E., Natural polyphenols (vegetable tannins) as drugs: Possible modes of action, J. Nat. Prod. 1996, 59, 205-215.
54. Maeda-Yamamoto, M., Kawahara, H., Tahara, N., Tsuji, K., et al., Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells, J. Agric. Food Chem. 1999, 47, 2350-2354.
55. Okabe, S., Fujimoto, N., Sueoka, N., Suganuma, M., Fujiki, H., Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array, Biol. Pharm. Bull. 2001, 24, 883-886.
56. Fassina, G., Vene, R., Morini, M., Minghelli, S., et al., Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate, Clin. Cancer Res. 2004, 10, 4865-4873.
57. Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols, J. Nutr. 2000, 130, 2073S-2085S.
58. Chow, H. H., Cai, Y., Hakim, I. A., Crowell, J. A., et al., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clin. Cancer Res. 2003, 9, 3312-3319.